Acinetobacter Baumannii News and Research

RSS

Antibiotic resistance in dolphins mirrors disturbing trend in humans

Antibiotic resistance in bottlenose dolphins shows that up to 88% of pathogenic organisms in this species is resistant to one or more antibiotics. This finding offers very useful insights into the identical phenomenon in humans. This species is termed a sentinel species, which means it reflects environmental risks to humans in advance of their occurrence in humans.

16 Sep 2019

Researchers discover elastic polymer with broad-spectrum antimicrobial properties

Researchers from North Carolina State University have found that an elastic polymer possesses broad-spectrum antimicrobial properties, allowing it to kill a range of viruses and drug-resistant bacteria in just minutes - including methicillin-resistant Staphylococcus aureus.

2 Aug 2019

Study analyzes high capacity of A. baumannii to persist on various surfaces

A group in the Department of Immunology, Microbiology and Parasitology at the UPV/EHU has conducted an in-depth study into the capacity to survive of the Acinetobacter baumannii bacterium as well as the strategies it uses to survive.

16 Jul 2019

New strategy may prevent spread of drug resistance

Spotless surfaces in hospitals can hide bacteria that rarely cause problems for healthy people but pose a serious threat to people with weakened immune systems.

10 Jan 2019

In-hospital mortality higher among patients with drug-resistant infections

In one of the largest studies to measure the burden of antibiotic resistance in a low- or middle-income country, researchers at the Center for Disease Dynamics, Economics & Policy report that in-hospital mortality is significantly higher among patients infected with multi-drug resistant or extensively drug resistant pathogens including Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii.

17 Nov 2018

Researchers discover key factors behind intestinal inflammation in CVID patients

Oregon State University researchers have discovered two key factors behind the intestinal inflammation that plagues people suffering from a disorder that affects their immune system.

14 Nov 2018

Bacterium causing nosocomial infections uses tiny finger-like structures to infect medical tools

The antibiotic-resistant Acinetobacter baumannii bacterium is one of the most globally harmful bacteria that causes nosocomial infections.

1 Jun 2018

Study finds rise in multi-drug resistant infections among U.S. children

Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise, according to results of a recent study published in the Journal of the Pediatric Infectious Diseases Society on March 22.

14 May 2018

Study examines trends of antibiotic-resistant A. baumannii infections in children

In the first national study of the prevalence of antibiotic-resistant Acinetobacter baumannii infections in children across the US, researchers from Center for Disease Dynamics, Economics, & Policy (CDDEP) in Washington, DC and Rush University in Chicago, IL examined national and regional trends of antibiotic resistance in clinical specimens over a 13-year period.

3 May 2018

New class of antimicrobial polymers can kill five hard-to-treat multidrug-resistant bacteria

An international research team led by the Institute of Bioengineering and Nanotechnology of the Agency for Science, Technology and Research and IBM Research developed a synthetic molecule that can kill five deadly types of multidrug-resistant bacteria with limited, if any, side effects.

7 Mar 2018

Communication breakdowns between care facilities can pave way for drug-resistant infection

Communication breakdowns between care facilities can pave the way for outbreaks of infection, according to research on the spread of an extensively drug-resistant bacterium.

21 Sep 2017

New antibiotic development slowing - warns World Health Organization

According to a new report from the World Health Organization (WHO) released yesterday, antibiotics development at present is not at par with the rising antimicrobial resistance worldwide and soon the demand may outgrow the supply. The WHO warns that this could mean that pathogens causing these infections could mean a great threat for humans in the coming years.

19 Sep 2017

Antibiotic-resistant bacteria work together to cause infection, research suggests

What's worse than getting exposed to a kind of bacteria that modern antibiotics can't kill? Getting exposed to more than one - because they may work together to cause an infection, new research suggests.

12 Sep 2017

Breast milk protective against bacterial infections

A new study has found that the complex mixture of sugars, proteins and fats in mother’s milk possesses certain properties that can protect babies against bacterial infections like Streptococci too. Researchers from Vanderbilt University looked at the antibacterial properties of breast milk and found that the sugars in it have antibacterial properties and also work to enhance the antibacterial properties of the proteins in breast milk.

21 Aug 2017

Entasis and GARDP partner to develop oral antibiotic for treatment of drug-resistant gonorrhea

Zoliflodacin, a novel first-in-class oral antibiotic and one of the only treatments in development to address the rapidly-growing threat of drug-resistant gonorrhea will enter pivotal trials, thanks to a new partnership between the not-for-profit Global Antibiotic Research and Development Partnership and Entasis Therapeutics.

7 Jul 2017

Triple combination of ineffective antibiotics provides new weapon to fight against super bacteria

In the fight against super bacteria, University at Buffalo scientists are relying on strength in numbers to win the battle against drug resistance.

25 May 2017

Researchers use novel phage therapy to treat patient infected with multidrug-resistant bacterium

Scientists and physicians at University of California San Diego School of Medicine, working with colleagues at the U.S. Navy Medical Research Center - Biological Defense Research Directorate, Texas A&M University, a San Diego-based biotech and elsewhere, have successfully used an experimental therapy involving bacteriophages -- viruses that target and consume specific strains of bacteria -- to treat a patient near death from a multidrug-resistant bacterium.

25 Apr 2017

Scientists develop new drug that combats two ‘priority pathogens’

Scientists at St. Boniface Hospital Albrechtsen Research Centre and the University of Manitoba have developed a drug that combats 2 of the top 10 "priority pathogens" recently defined by the World Health Organization as antiobiotic-resistant bacteria requiring new interventions.

20 Apr 2017

McMaster researchers find new way to combat world's worst infectious diseases

McMaster University researchers have found a new way to treat the world's worst infectious diseases, the superbugs that are resistant to all known antibiotics.

6 Mar 2017

Innovative ways to target antibiotic resistance in short term

There has been much recent talk about how to target the rising tide of antibiotic resistance across the world, one of the biggest threats to global health today.

3 Mar 2017